[{"Assets_0_Q3_USD":"60878000000.0","CIK":"882095","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.68","CommonStockDividendsPerShareDeclared_3_Q3_USD":"2.04","CommonStockSharesIssued_0_Q3_shares":"1253000000.0","CommonStockSharesOutstanding_0_Q3_shares":"1253000000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.29","EarningsPerShareBasic_3_Q3_USD":"-1.14","EarningsPerShareDiluted_1_Q3_USD":"0.29","EarningsPerShareDiluted_3_Q3_USD":"-1.14","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"78838305412.0","MinorityInterest_0_Q3_USD":"26000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"6252000000.0","NetIncomeLoss_1_Q3_USD":"360000000.0","NetIncomeLoss_3_Q3_USD":"-1428000000.0","OfficialName":"Gilead Sciences Inc. Common Stock","PaymentsOfDividends_3_Q3_USD":"2591000000.0","ProfitLoss_1_Q3_USD":"353000000.0","ProfitLoss_3_Q3_USD":"-1455000000.0","RevenuesConverted_1_Q3_USD":"6577000000.0","RevenuesConverted_3_Q3_USD":"17268000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"17471000000.0","StockholdersEquity_0_Q3_USD":"17445000000.0","Ticker":"GILD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1261000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1257000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1255000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1257000000.0","filed":"20201104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"GILEAD SCIENCES INC","period":"20200930","qtrs":"0","uom":"USD"}]